arrow
A

Adam M. Sonabend

Northwestern University
H指数:42
被引数:6,355

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Glioma-intrinsic MAPK/ERK signaling promotes immunotherapy efficacy through T cell infiltration and interferon responses

胶质瘤-内在MAPK/ERK信号通过T细胞浸润和干扰素反应促进免疫治疗效果

2026-06-250
OAAI
STING activation induces cytotoxic and immune responses in meningiomas via inflammatory cell death pathways

STING激活通过炎症性细胞死亡通路诱导脑膜瘤中的细胞毒性及免疫反应

2026-02-120
OAAI
Dynamic release of extracellular particles after opening of the blood-brain barrier predicts glioblastoma susceptibility to paclitaxel

血脑屏障开放后细胞外粒子的动态释放预测胶质母细胞瘤对紫杉醇的敏感性

2025-12-160
OAAI
Multi-Omic Profiling of Human Peritumoral Brain Following Ultrasound-Mediated BBB Disruption Reveals Microglial Reprogramming and Enhanced Endothelial Crosstalk

超声介导的血脑屏障破坏后的人体肿瘤周围脑组织的多组学分析揭示了小胶质细胞的重新编程和增强的血管内皮细胞互作

2025-11-010
OAAI
YBX1&YBX3 as novel targets to potentiate immune checkpoint blockade response in gliomas

YBX1&YBX3作为增强胶质瘤免疫检查点阻断反应的新型靶点

2025-11-010
PRE
Spatial Immunophenotypic Characterization of Immune Exclusion and Dysfunction via Collagen-Rich Fibrous Septa in Chordomas

通过富含胶原的纤维性间隔对脊索瘤中免疫排斥和功能障碍的空间免疫表型表征

2025-11-010
OAAI
DECODING THE SPATIAL ARCHITECTURE OF INTEGRATED ELECTROPHYSIOLOGICAL AND TRANSCRIPTOMIC DIVERSITY IN MALIGNANT BRAIN TUMORS

解码恶性脑肿瘤中整合电生理和转录组多样性空间架构

2025-11-010
OAAI
SONOBIRD: A PHASE 3 TRIAL OF BLOOD-BRAIN-BARRIER (BBB) OPENING WITH THE SONOCLOUD-9 IN RECURRENT GLIOBLASTOMA PATIENTS RECEIVING IV CARBOPLATIN

SONOBIRD:一项使用SONOCLOUD-9实现血脑屏障(BBB)开放的第3期临床试验,研究对象为接受静脉注射卡铂治疗的复发性胶质母细胞瘤患者

2025-11-010
OAAI
Focused ultrasound-mediated blood-brain barrier disruption, combined with antigen-presenting cell activation, promotes CNS antigen-specific T cell immunity and bypasses immunotherapy resistance mechanism in malignant brain tumors

聚焦超声介导的血脑屏障破坏,结合抗原提呈细胞激活,促进中枢神经系统抗原特异性T细胞免疫,并绕过恶性脑肿瘤的免疫疗法耐药机制。

2025-11-010
OAAI
Targeting TGFβ-mediated B cell suppression enhances anti-PD-1 efficacy in glioblastoma

靶向TGFβ介导的B细胞抑制可增强胶质母细胞瘤中抗PD-1的疗效

2025-11-010
OAAI
Synergistic STING activation in meningioma neoplastic and immune populations triggers programmed necrosis and modulates the collagen-rich immunosuppressive microenvironment

在脑膜瘤的肿瘤和免疫细胞群体中,协同的STING激活会触发程序性坏死并调节富含胶原的免疫抑制性微环境。

2025-11-010
OAAI
Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial

作者更正: 溶瘤DNX-2401病毒疗法联合pembrolizumab治疗复发性胶质母细胞瘤: 1/2期试验

2025-07-210
OA
Dual aVß8 Integrin and PD-1 Blockade Overcomes TGFβ-Mediated B-Cell Suppression to Enhance Anti-Tumor Immunity

双aVß8整合素和PD-1阻断克服TGFβ介导的B细胞抑制以增强抗肿瘤免疫

2025-06-011
PRE
Integrating Histologic and Molecular Features in Meningiomas
2025-04-010
PRE
Endothelial response to blood-brain barrier disruption in the human brain
2024-12-260
OA
PHARMACOKINETIC ANALYSIS OF CARBOPLATIN AND FLUORESCEIN BRAIN PENETRATION AND PERMANENCE FOLLOWING ULTRASOUND-BASED BLOOD-BRAIN BARRIER OPENING ON GLIOBLASTOMA CLINICAL TRIAL
2024-11-110
PRE
EPIGENETIC POTENTIATION OF ANTI-TUMOR IMMUNE RESPONSES USING VIRAL MIMICRY IN GLIOMAS
2024-11-110
PRE